Discover 2,396 paid clinical trials in Annapolis, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,396
Active & Responsive
Interventional Study of Infigratinib in Children < 3 Years Old With Achondroplasia (ACH)
for
Achondroplasia
Location: Baltimore MD, Ottawa, Montreal, Madison WI, Oakland CA
Sponsor: QED Therapeutics, a BridgeBio company
Sex: All
Age: 0 - 2
Code: NCT07169279
Phase2, Recruiting
Active & Responsive
Personalized Neoantigen Vaccine Plus IL-12 (INO-9012) Versus Active Surveillance in Subjects With High-Risk HCC
for
HCC
Location: Baltimore MD, New York NY, New Orleans LA
Sponsor: Geneos Therapeutics
Sex: All
Age: 18+
Code: NCT07722741
Phase2, Recruiting
Active & Responsive
Anastomotic Safety and Surveillance Using Real-time Enhanced Sensing Using xBar
for
Colorectal Cancer
Location: Baltimore MD, New York NY, Pittsburgh PA, Louisville KY,
Sponsor: Exero Medical Ltd.
Sex: All
Age: 21+
Code: NCT07337590
Recruiting
Active & Responsive
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
for
Huntington Disease
Location: Baltimore MD, Washington D.C. DC, Philadelphia PA,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 21 - 70
Code: NCT07326709
Phase3, Recruiting
Active & Responsive
Remote Sputum Collection in Cystic Fibrosis
for
Cystic Fibrosis, Infections
Location: Baltimore MD, Philadelphia PA, Denver CO, Spokane WA
Sponsor: University of Pennsylvania
Sex: All
Age: 18+
Code: NCT06950892
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
for
Obesity, Overweight
Location: Hyattsville MD, Baltimore MD, Norfolk VA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07321886
Phase3, Recruiting
Active & Responsive
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
for
Triple Negative Breast Neoplasms
Location: Baltimore MD, Clinton MD, Washington D.C. DC,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06841354
Phase3, Recruiting
Active & Responsive
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
for
Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC,
Location: Columbia MD, Fairfax VA, Newark DE, Philadelphia PA,
Sponsor: Immuneering Corporation
Sex: All
Age: 18+
Code: NCT07562152
Phase3, Recruiting
Active & Responsive
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer
for
Metastatic Castration-Resistant Prostate Cancer
Location: Columbia MD, Fairfax VA, Asheville NC, Ann Arbor MI,
Sponsor: Zenith Epigenetics
Sex: Male
Age: 18+
Code: NCT04986423
Phase2, Recruiting
Active & Responsive
Allopregnanolone and Dynamic GABA-A Receptor Plasticity in Selective Serotonin Reuptake Inhibitor Responsive Premenstrual Dysphoric Disorder
for
Premenstrual Dysphoric Disorder (PMDD)
Location: Baltimore MD, Charlottesville VA
Sponsor: Johns Hopkins University
Sex: Female
Age: 18 - 50
Code: NCT06704594
Recruiting
Active & Responsive
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
for
Chronic Migraine
Location: Baltimore MD, McLean VA, Philadelphia PA,
Sponsor: Merz Therapeutics GmbH
Sex: All
Age: 18+
Code: NCT07018713
Phase3, Recruiting
Active & Responsive
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
for
Episodic Migraine
Location: Baltimore MD, McLean VA, Philadelphia PA,
Sponsor: Merz Therapeutics GmbH
Sex: All
Age: 18+
Code: NCT07018700
Phase3, Recruiting
Active & Responsive
Antibiotic Device for Osteomyelitis of the Extremities Pivotal Trial - Genex With Gentamicin.
for
Osteomyelitis
Location: Baltimore MD, Oradell NJ, Indianapolis IN, San Diego CA
Sponsor: Biocomposites Ltd
Sex: All
Age: 18+
Code: NCT07270380
Recruiting
Active & Responsive
Motiva Implants® Post-Approval Study
for
Breast Implant
Location: Baltimore MD, Chevy Chase MD, Washington D.C. DC,
Sponsor: Motiva USA LLC
Sex: Female
Age: 22+
Code: NCT06938399
Recruiting
Active & Responsive
A Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome
for
Phelan-McDermid Syndrome
Location: Washington D.C. DC, Chevy Chase MD, Charlottesville VA,
Sponsor: Neuren Pharmaceuticals Limited
Sex: All
Age: 3 - 12
Code: NCT07281079
Phase3, Recruiting
Active & Responsive
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
for
Major Depressive Disorder
Location: Towson MD, Philadelphia PA, New York NY, Raleigh NC,
Sponsor: Syndeio Biosciences, Inc
Sex: All
Age: 18 - 64
Code: NCT07115329
Phase2, Recruiting
Active & Responsive
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
for
Endometrial Cancer
Location: Brandywine MD, Fairfax VA, Doylestown PA, New York NY,
Sponsor: Faeth Therapeutics
Sex: Female
Age: 18+
Code: NCT06463028
Phase2, Recruiting
Active & Responsive
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
for
Platinum-resistant Ovarian Cancer,
Location: Silver Spring MD, Pittsburgh PA, Stony Brook NY,
Sponsor: Genelux Corporation
Sex: Female
Age: 18+
Code: NCT05281471
Phase3, Recruiting
Active & Responsive
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
for
Treatment Resistant Depression
Location: Baltimore MD, Philadelphia PA, Moosic PA, Woodbury NY,
Sponsor: LivaNova
Sex: All
Age: 18+
Code: NCT03887715
Recruiting
Active & Responsive
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
for
Treatment Resistant Depression
Location: Baltimore MD, Rockville MD, Philadelphia PA,